← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2003Last known activity
May 1, 2012
Timeline
1990s
- Jan 1, 1997
Agennix— Founded
2000s
- Nov 1, 2009
GPC Biotech Inc.— Acquired
Drugs by trial phase (10 distinct, 20 trials)
Phase 3 (2 own, 1 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Verrucous
- Communicable Diseases
- Cross Infection
- Head and Neck Neoplasms
- Infections
- Laryngeal Diseases
- Laryngeal Neoplasms
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasms
- Neoplasms, Unknown Primary
- Oropharyngeal Neoplasms
- Paranasal Sinus Neoplasms
- Prostatic Neoplasms
- Recurrence
- Salivary Gland Neoplasms
- Sepsis
- Tongue Neoplasms
- Toxemia
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (21)
- NCT01528137CollaboratorPhase 1May 1, 2012
- NCT01168882Lead sponsorPhase 1Nov 1, 2011
- NCT01273779Lead sponsorPhase 2/Phase 3Jun 1, 2011
- NCT00854633Lead sponsorPhase 1/Phase 2Jun 1, 2009
- NCT00706862Lead sponsorPhase 3Feb 1, 2009
- NCT00707304Lead sponsorPhase 3Nov 1, 2008
- NCT00630656Lead sponsorPhase 2Apr 1, 2008
- NCT01220284CollaboratorPhase 1Feb 1, 2008
- NCT00473720CollaboratorPhase 1May 1, 2007
- NCT00480623Lead sponsorPhase 1May 1, 2007
- NCT00125411Lead sponsorPhase 1Mar 1, 2007
- NCT00450970Lead sponsorPhase 3Feb 1, 2007
- NCT00370383Lead sponsorPhase 2Jul 1, 2006
- NCT00329329Lead sponsorPhase 1May 1, 2006
- NCT00313456Lead sponsorPhase 1Mar 1, 2006
Details
- Founded
- Heidelberg, DE Jan 1, 1997
- Last known activity
- May 1, 2012